Literature DB >> 12725689

Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses.

Eva Wattrang1, David M Jessett, Phillip Yates, Lisbeth Fuxler, Duncan Hannant.   

Abstract

The production of interferon (IFN), interleukin-6 (IL-6), and tumor necrosis factor (TNF) was monitored in horses during the course of influenza A2 virus infections. The effects of two virus strains, Newmarket/2/93 and Sussex/89, were compared, of which the latter is considered the more pathogenic in terms of clinical signs. Ten naive ponies were infected with influenza A/equine/Sussex/89 and 10 with influenza A/equine/Newmarket/2/93, respectively. As expected ponies infected with Sussex/89 showed the most pronounced clinical signs but there was no notable difference in viral excretion compared with Newmarket/2/93. IFN was detected in nasal secretions of all ponies infected with Sussex/89 but only in 2 ponies infected with Newmarktet/2/93. IFN was not detected in serum of any animal. IL-6 activity was detected in nasal secretions of all experimental animals from day 2 and onwards, but showed markedly higher IL-6 responses were observed in ponies infected with Sussex/89. No TNF activity was detected in any of the samples collected. In summary, equine influenza A 2 infections elicited local, and in some cases systemic, IFN and IL-6 responses in the ponies. Interestingly, there was some evidence that the duration and levels of cytokine responses may be related to the pathogenicity of the influenza strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725689     DOI: 10.1089/088282403763635456

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  13 in total

1.  Dynamics of influenza virus infection and pathology.

Authors:  Roberto A Saenz; Michelle Quinlivan; Debra Elton; Shona Macrae; Anthony S Blunden; Jennifer A Mumford; Janet M Daly; Paul Digard; Ann Cullinane; Bryan T Grenfell; John W McCauley; James L N Wood; Julia R Gog
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

2.  Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Authors:  Alida Ault; Alyse M Zajac; Wing-Pui Kong; J Patrick Gorres; Michael Royals; Chih-Jen Wei; Saran Bao; Zhi-yong Yang; Stephanie E Reedy; Tracy L Sturgill; Allen E Page; Jennifer Donofrio-Newman; Amanda A Adams; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers; Gary J Nabel; Srinivas S Rao
Journal:  Vaccine       Date:  2012-03-23       Impact factor: 3.641

3.  Genomic analysis and mRNA expression of equine type I interferon genes.

Authors:  Olivier Detournay; David A Morrison; Bettina Wagner; Behdad Zarnegar; Eva Wattrang
Journal:  J Interferon Cytokine Res       Date:  2013-06-17       Impact factor: 2.607

4.  Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.

Authors:  T M Chambers; M Quinlivan; T Sturgill; A Cullinane; D W Horohov; D Zamarin; S Arkins; A García-Sastre; P Palese
Journal:  Equine Vet J       Date:  2009-01       Impact factor: 2.888

5.  Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.

Authors:  A Cristina Paulo; Margarida Correia-Neves; Tiago Domingos; Alberto G Murta; Jorge Pedrosa
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

6.  Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece (2003 and 2007): evidence for reassortment between evolutionary lineages.

Authors:  Maria Bountouri; Eirini Fragkiadaki; Vasileios Ntafis; Theo Kanellos; Eftychia Xylouri
Journal:  Virol J       Date:  2011-07-14       Impact factor: 4.099

7.  Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.

Authors:  H G W Pouwels; S M A Van de Zande; L J I Horspool; M J H Hoeijmakers
Journal:  Vet Rec       Date:  2014-05-02       Impact factor: 2.695

8.  Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.

Authors:  Irina V Alymova; Ian A York; Jonathan A McCullers
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

9.  A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.

Authors:  Lila M Zarski; Wendy E Vaala; D Craig Barnett; Fairfield T Bain; Gisela Soboll Hussey
Journal:  Front Vet Sci       Date:  2021-06-10

Review 10.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.